NCT00266266|CompletedDMC
Human Papilloma Virus DNA Self-Test
HPV
Loading search results
HPV
Sponsor study identifier
observational
171
1 country
1
Study Start
January 2004
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
October 2008
Actual (reported)Study Completion
October 2008
Actual (reported)HPV DNA testing by a clinician has been shown to be highly sensitive in detecting cervical disease. Can we prove that HPV self-testing will be sufficiently sensitive to detect disease in high risk population who for various reasons would not have routine pap smear screening?
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
October 2008
Actual (reported)Click on a node to explore related trials.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
January 2004
Date type not reportedThis date has not been verified as actual or estimated.
December 15, 2005
Actual (reported)December 16, 2005
Actual (reported)October 2008
Actual (reported)October 2008
Actual (reported)HPV DNA self-testing device to detect disease in patients with abnormal Pap smear
To assess the concordance of HPV DNA self-testing device to detect disease in patients with abnormal Pap smear. Patients with a positive HPV Self-test by vaginal swab or vaginal tampon will be compared to the physician test results for concordance. Following patient self-sample collection, physician will collect cervical samples using a spatula. A self testing device which patients can use at their convenience will be beneficial in decreasing the incidence of cervical cancer in Kentucky.
Patient will self-test immediately prior to their standard physician papsmear
Abnormal pap smear ASCUS or higher Age 18-postmenopausal
James Graham Brown Cancer Center
Louisville, Kentucky, 40202, United States
Robert Edwards, MD
University of Louisville,James Graham Brown Cancer Center
171 participants (actual enrollment reported by the registry).
First Submitted
December 15, 2005
First Posted
December 16, 2005
Study Start
January 2004
Date type not reportedThis date has not been verified as actual or estimated.
Zinc Sulfate for Human Papillomavirus (HPV)
Contact the study team to confirm eligibility.
Primary Completion
October 2008
Actual (reported)Study Completion
October 2008
Actual (reported)Last Updated
December 29, 2017
Record last verified: 2017-12
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: